Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
Completed clinical trial evaluating how atypical antipsychotics influence appetite and eating behavior in people with schizophrenia and schi…
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome [Phase 3]
Phase 3 trial comparing aripiprazole with standard of care on non-HDL cholesterol in adults with schizophrenia or bipolar I disorder and met…
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial update assessing cataract risk associated with quetiapine (Seroquel) and risperidone (Risperdal) in people with schizophrenia …
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder [NA]
Clinical trial update about a follow-up study of intramuscular olanzapine depot in patients with schizophrenia or schizoaffective disorder. …
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders [Phase 1]
A Phase 1 pharmacokinetic study evaluating risperidone and topiramate given alone and in combination in patients with bipolar disorder or sc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone [Phase 1]
Phase 1 study evaluating the effects of immediate-release paliperidone on QT and QTc intervals in patients with schizophrenia or schizoaffec…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
A phase 3 randomized trial comparing a long-acting injectable risperidone formulation to olanzapine tablets in adults with schizophrenia or …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations [Phase 1]
Phase 1 pharmacokinetic study comparing paliperidone Extended-Release with risperidone Immediate-Release in adults with Schizophrenia or Sch…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder [Phase 1]
This Phase 1 safety and pharmacokinetic study evaluated the extended-release osmotic-release (ER OROS) formulation of paliperidone in pediat…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients
The trial evaluated the safety and effectiveness of risperidone for acute psychosis in patients with schizophrenia or related disorders. The…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia
A terminated clinical trial evaluated the safety of risperidone in obese or overweight patients with schizophrenia or schizoaffective disord…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
This clinical trial update reports the completion of a Phase 3 study assessing how long it takes patients to relapse after switching from an…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine [Phase 1]
A Phase 1 study update assessing the effects of extended-release paliperidone and quetiapine on QT and QTc intervals in patients with schizo…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-acting Risperidone by Injection [Phase 3]
A Phase 3 study evaluated how useful a Risperdal Consta treatment guidebook is for doctors when adults with schizophrenia or schizoaffective…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder [Phase 3]
A Phase 3 clinical trial evaluated monthly injections of risperidone for efficacy and safety in adults with schizophrenia or schizoaffective…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients. [Phase 3]
Phase 3 long-term safety study of long-acting injectable risperidone in schizophrenia or schizoaffective disorder patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder. [Phase 3]
Update on long-term safety results from a Phase 3 study of a long-acting injectable risperidone in adults with schizophrenia or schizoaffect…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial assessing the effects of risperidone and olanzapine on blood glucose in patients with schizophrenia or schizoaffective disorde…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis [Phase 4]
This document reports the completion of a Phase 4 trial evaluating risperidone long-acting injectable in early psychosis.
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Study of Amantadine for Weight Stabilization During Olanzapine Treatment [Phase 1]
A Phase 1 study evaluating whether amantadine can stabilize weight during olanzapine treatment has been completed.
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Pfizer completed a Phase 3 trial evaluating varenicline (Chantix) for smoking cessation in patients with schizophrenia or schizoaffective di…
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants [Phase 2, Phase 3]
An update on Phase 2 and Phase 3 trials evaluating whether omega-3 fatty acid EPA, combined with antioxidants, can treat schizophrenia and r…
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder [Phase 4]
Phase 4 trial update on the efficacy of quetiapine for patients with schizophrenia and comorbid substance use disorder; results were posted …
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Pregnenolone Augmentation in the Treatment of Patients With Recent-Onset Schizophrenia [Phase 4]
Phase 4 trial evaluating pregnenolone augmentation in patients with recent-onset schizophrenia; the study status is completed, but no result…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Schizophrenic Patients Taking Part in Integrated Care Program
The AstraZeneca-sponsored clinical trial involving schizophrenia and related psychotic disorders has been terminated.